Heng-chih Pan
Keelung Branch, 204
Keelung, TNQ, Taiwan
Keelung, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Cardiovascular and renal outcomes of combined SGLT2 inhibitors and GLP-1 receptor agonists versus monotherapy in patients with type 2 diabetes mellitus: a network meta-analysis.
Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Published: March 26, 2026
Association of urinary post-translationally modified fetuin-a and outcomes in acute kidney disease.
Journal: BMC nephrology
Published: January 03, 2026
Comparison of Acute Kidney Disease Staging by Estimated Glomerular Filtration Rate and by Serum Creatinine Ratio in Patients With Dialysis-requiring Acute Kidney Injury: A National Cohort Study From Taiwan.
Journal: Kidney medicine
Published: November 10, 2025
Perfluoroalkyl substances exposure and kidney function decline in a community-based prospective cohort.
Journal: Ecotoxicology and environmental safety
Published: June 03, 2025
Medical treatment for diabetic acute kidney disease from 2012 to 2024: advances, prescription trends, and future directions.
Journal: Kidney research and clinical practice
Published: May 02, 2025
Real-world trends in glucagon-like peptide-1 receptor agonists prescribing in acute kidney disease: a global federated-network study of dialysis-requiring acute kidney injury survivors.
Journal: Kidney research and clinical practice
Published: April 14, 2025
Association of Angiotensin Receptor-Neprilysin Inhibitors Use and Better Cardiorenal Outcomes in Patients With Heart Failure and Acute Kidney Disease.
Journal: Cardiovascular drugs and therapy
Published: April 08, 2025
Machine-learning assisted discovery unveils novel interplay between gut microbiota and host metabolic disturbance in diabetic kidney disease.
Journal: Gut microbes
Published: March 06, 2025
Immune checkpoint inhibitors-associated acute kidney injury: a systematic review and meta-analysis of incidence, kidney recovery, and recurrent risk.
Journal: Cancer immunology, immunotherapy : CII
Published: February 27, 2025
Last Updated: 09/26/2026